“…Important caveats must be considered in interpreting LTL (Aviv et al, 2006; Epel, 2012), e.g., (a) distinguishing between telomere shortening in the individual leukocyte vs. “apparent” telomere shortening when examining average LTL, due to a re-distribution of leukocyte cell types having different telomere lengths, such as naïve vs. memory T cells; (b) the relationship of LTL to TL in other tissues has not been well established, and TL varies by tissue (although TL is generally positively correlated across certain, but not all, tissues within individuals) (Daniali et al, 2013; Dlouha et al, 2014; Friedrich et al, 2000; Gadalla et al, 2010; Lukens et al, 2009; Mitchell et al, 2014; Nakamura et al, 2002; Takubo et al, 2002; Takubo et al, 2010; Thomas et al, 2008); (c) different results may derive from different DNA extraction and assay methods and different laboratories (Aubert et al, 2012; Aviv et al, 2011; Cunningham et al, 2013; Montpetit et al, 2014; Nieratschker et al, 2013); and (d) even slight DNA degradation can yield spurious TL measuements (Dlouha et al, 2014). Further, many subject-level variables, such as age, sex, genetic polymorphisms, “resiliency,” education, history of early life adversities, parental responsiveness, socioeconomic status, health behaviors, diet, and latent or active viral infections (e.g., cytomegalovirus or herpes virus) may affect LTL, independent of the disease process being studied (Adler et al, 2013; Asok et al, 2013; Aviv et al, 2011; Effros, 2011; Eitan et al, 2014; Epel, 2012; Epel, 2009; Gardner et al, 2014; Gutierrez-Rodrigues et al, 2014; Jacobs et al, 2013; Lung et al, 2005; Nieratschker et al, 2013; Price et al, 2012; Puterman et al, 2013; Puterman et al, 2010; Rizzo et al, 2013; Spyridopoulos et al, 2009; Wikgren et al, 2012a).…”